Pharmaceutical companies wouldn’t be able to do what they do well without the help of the role of Medical Science Liaisons, most commonly called MSLs. The role of Medical Science Liaisons is to provide the expertise to disseminate scientific and clinical information to the medical community, which in turns enables innovation in drug development and [...]
Are you wondering how to become a Medical Science Liaison (MSL)? A MSL connects life science organizations to industry thought leaders (or KOLs) by sharing scientific and clinical information on products and involving these KOLs in research, speaking or consulting activities. Here’s what you can expect from your journey of medical science liaison training and [...]
We have often heard through our conversations with clients how Medical Affairs programs suffer from the “revolving door” disease, meaning that a significant contingent of MSLs don’t stick around for long periods at the organizations (yes, with an S…!) they work for. To some degree, this also applies to upper management roles. So, what are [...]
New Medical Science Liaisons come mostly, and unsurprisingly, from various areas of medical fields. We recently conducted surveys to learn about the prior profiles of new MSLs and whether they entered the industry as new MSLs or became MSL while working in pharma. As expected, and as the survey of 789 Medical Science Liaisons results [...]
Learning about KOL meeting preferred frequency with Medical Science Liaisons, that is when Thought Leaders can or want to meet MSLs, is an important component of building trust in the MSL-KOL relationships. Since most of the organizations’ field teams coordinate and set the pace for these interactions, it becomes increasingly important to understand what Thought [...]
The Medical Science Liaison job has been growing over the past 30 years, at first being mostly developed and refined in North America and gradually taking hold in other parts of the world, as companies gradually implemented Medical Affairs function throughout their organization. Like any other career, a Medical Science Liaison job is not immune [...]
The Altered Pharmaceutical Thought Leader Pool: How the Implementation of the Sunshine Act and CMS Open Payment Program Changed the KOL Landscape Since the adoption of the Sunshine Act in 2010 and the subsequent thought leaders’ payments reporting on the CMS Open Payment Program in 2014, many things have changed for pharmaceutical companies. It took [...]
Research shows what European KOLs think of MSLs they interact with. Through the deployment of scientific field teams (MSLs), organizations’ intentions are to share medical and clinical knowledge of products with the thought leaders who in turn can spread the information to physician communities and ultimately enhance patient experiences. In the process, thought leaders become [...]
A new research study MSL Performance Metrics: Valuing the Role Throughout a Product's Lifecycle reveals key indicators on MSL performance reviews and identify the most common trends and perceptions among the medical affairs executives including how they see the 3 phases of MSL Performance Reviews. The full study presents an assessment of current practices, feedback from 37 [...]
The Instagram stars of therapeutic areas and disease management, Digital Opinion Influencers (DOIs) are a growing online presence that often can as effectively communicate and advocate for pharmaceutical solutions and products as Key Opinion Leaders (KOLs) do in more traditional channels (publications, conference presentations, perhaps even treating patients). The possibility of that very comparison makes [...]
